海角破解版

Human iPSC-Derived Astrocytes

Frozen astrocytes differentiated from human induced pluripotent stem cell line, SCTi003-A

Certain products are only available in select territories. Please contact your local Sales representative or Product & Scientific Support at techsupport@stemcell.com for further information.

Human iPSC-Derived Astrocytes

Frozen astrocytes differentiated from human induced pluripotent stem cell line, SCTi003-A

Catalog #
(Select a product)
Frozen astrocytes differentiated from human induced pluripotent stem cell line, SCTi003-A
Request Pricing Request Pricing

Product Advantages


  • Save time with ready-to-use, cryopreserved human astrocytes

  • Achieve high purity and functionality with astrocytes produced using a fully serum-free system

  • Culture and maintain long-term with the STEMdiff? Astrocyte Serum-Free Maturation Kit

  • Ensure relevance with neuron-astrocyte co-cultures generated with the same genetic background

  • Model neurological development, disease, drug screening, toxicity, and cell therapy applications with flexibility

Products for Your Protocol
To see all required products for your protocol, please consult the Protocols and Documentation.

Overview

Accelerate your neural research with confidence using high-quality, ready-to-use Human Induced Pluripotent Stem Cell (iPSC)-Derived Astrocytes. These cryopreserved glial cells are manufactured from the highly characterized human iPSC control line, SCTi003-A (Catalog #200-0511), using a completely serum-free system consisting of STEMdiff? SMADi Neural Induction Kit (Catalog #08581), STEMdiff? Astrocyte Differentiation Kit (Catalog #100-0013), and STEMdiffTM Astrocyte Serum-Free Maturation Kit (Catalog #100-1666). Ready for downstream applications immediately after thawing in the STEMdiff? Astrocyte Serum-Free Maturation Kit, these astrocytes are highly pure (≥ 70% S100B-positive, ≥ 60% GFAP-positive, and < 19% DCX-positive neuron precursors) and are versatile tools for modeling human neurological development and diseases, co-culture applications, drug screening, toxicity testing, and cell therapy validation.

Consent has been given for both academic and commercial use of this research-use-only (RUO) product. Blood samples are ethically sourced using Institutional Review Board (IRB) or other regulatory authority-approved consent forms and protocols. For donor details and cell quality characterization of the source cell banks, refer to the Data Figures section below. For additional details, refer to the lot-specific Certificate of Analysis and Frequently Asked Questions about iPSC lines.
Contains
Human iPSC-Derived Astrocytes (Catalog #200-0980)
Subtype
Frozen
Cell Type
Astrocytes, Neural Cells, PSC-Derived
Species
Human
Cell and Tissue Source
Pluripotent Stem Cells
Application
Cell Culture, Functional Assay
Area of Interest
Disease Modeling, Drug Discovery and Toxicity Testing, Neuroscience, Stem Cell Biology

Data Figures

Human iPSC-Derived Astrocytes on Day 1, 3, and 7

Figure 1. Human iPSC-Derived Astrocytes Exhibit High-Quality Morphology

Cryopreserved Human iPSC-Derived Astrocytes generated from SCTi003-A iPSCs were thawed and plated onto Matrigel?-coated plates at 150,000 cells/cm? in STEMdiff? Astrocyte Serum-Free Maturation Kit. Astrocytes were incubated at 37°C and subsequently analyzed on Days 1, 3, and 7 by brightfield microscopy at 10x magnification. Astrocytes display the expected morphology, including a flattened, polygonal shape with enlarged cell bodies, and by Day 7, more pronounced stellate processes characteristic of mature astrocytes. iPSC = induced pluripotent stem cell.

Figure 2. Human iPSC-Derived Astrocytes Exhibit High Purity and Express Characteristic Glial  Markers

Figure 2. Human iPSC-Derived Astrocytes Exhibit High Purity and Express Characteristic Glial Markers

Cryopreserved Human iPSC-Derived Astrocytes generated from SCTi003-A iPSCs were thawed and cultured using the STEMdiff? Astrocyte Serum-Free Maturation Kit for 7 days and fixed for immunocytochemistry. (A) Day 7 astrocytes show high expression of astrocyte markers S100B (green) and GFAP (red), with low expression of the neuronal marker DCX (purple) (20× magnification, scale bar = 500??m). (B) The percentage of cells positive for S100β, GFAP, and DCX was quantified from five images per condition across three independent experiments, expressed relative to total DAPI-positive cells. S100β was expressed in 84% of cells, GFAP in 79%, and DCX in fewer than 3%. Error bars represent standard deviation (n = 3 biological replicates). iPSC = induced pluripotent stem cell.

Human iPSC-Derived Astrocytes Express Expected Levels of Genes Characteristic for Astrocytes

Figure 3. Human iPSC-Derived Astrocytes Express Expected Levels of Genes Characteristic for Astrocytes

Cryopreserved Human iPSC-Derived Astrocytes generated from SCTi003-A iPSCs were thawed and cultured using the STEMdiff? Astrocyte Serum-Free Maturation Kit for 7 days prior to analysis. Expression levels were measured by quantitative PCR (qPCR) and normalized to hPSC controls relative to housekeeping gene TBP. iPSC = induced pluripotent stem cell; hPSC = human pluripotent stem cell.

Human iPSC-Derived Astrocytes Uptake Excess Glutamate In Culture, Indicating Functional Maturity

Figure 4. Human iPSC-Derived Astrocytes Uptake Excess Glutamate In Culture, Indicating Functional Maturity

Cryopreserved Human iPSC-Derived Astrocytes generated from the SCTi003-A iPSCs were thawed and cultured in STEMdiff? Astrocyte Serum-Free Maturation Kit for 7 days. Prior to glutamate treatment, cells were incubated in BrainPhys? medium for 4 hours at 37°C and 5% CO?. Cells were then treated for 1 hour with either 50??M glutamate in BrainPhys? ("GLU") or water in BrainPhys? ("CTRL"). Glutamate levels in each sample were quantified using the Fluorometric Glutamate Assay Kit (Abcam, ab138883). Different colors represent distinct experimental setups. Bars represent mean ± standard deviation. (A) Glutamate concentration in the media (“Pre-Treatment”) and spent media (“Post-Treatment”). (B) Glutamate concentration in the cell lysates, extracted with Mammalian Cell Lysis Buffer (ABCAM, ab179835). iPSC = induced pluripotent stem cell.

Figure 5. Human iPSC-Derived Astrocytes Display Reactive Phenotype Upon Cytokine Stimulation

Figure 5. Human iPSC-Derived Astrocytes Display Reactive Phenotype Upon Cytokine Stimulation

Cryopreserved Human iPSC-Derived Astrocytes generated from the SCTi003-A iPSCs were thawed and cultured in STEMdiff? Astrocyte Serum-Free Maturation Kit for 7 days. Astrocytes were treated with either a vehicle control ("CTRL") or a pro-inflammatory cytokine cocktail ("A1") consisting of 30?ng/mL TNFα, 3?ng/mL IL-1α, and 400?ng/mL C1Qa for 24 hours. Following A1 treatment, astrocytes showed increased expression of C3 (marker of neurotoxic reactive astrocytes) and GBP2 (interferon response and inflammation marker). Expression levels were measured by quantitative PCR (qPCR) and normalized to hPSC controls relative to housekeeping gene TBP. Statistical significance was determined using an unpaired t-test (***p < 0.001). Bars represent mean ± standard deviation, with different colors indicating distinct experimental conditions. iPSC = induced pluripotent stem cell.

Figure 6. Human iPSC-Derived Astrocytes Can Be Co-Cultured with Neurons to Model Cell-Cell Interactions In Vitro

Figure 6. Human iPSC-Derived Astrocytes Can Be Co-Cultured with Neurons to Model Cell-Cell Interactions In Vitro

Representative immunocytochemistry images display Human iPSC-Derived Astrocytes co-cultured with forebrain neurons derived using the STEMdiff?-TF Forebrain Induced Neuron Differentiation Kit for 21 days and maintained in the STEMdiff? Forebrain Neuron Maturation Kit. Cells were stained for GFAP (green, astrocyte marker) and MAP2 (pink, neuronal dendrite marker). The presence of MAP2-positive neurons alongside GFAP-positive astrocytes demonstrates compatibility in co-culture conditions, supporting the viability and integration of neurons within an astrocyte-rich environment. Scale bar = 100 ?m.

Figure 7. Human iPSC-Derived Astrocytes Can Be Tri-Cultured with Neurons and Microglia to Model Cell-Cell Interactions In Vitro

Figure 7. Human iPSC-Derived Astrocytes Can Be Tri-Cultured with Neurons and Microglia to Model Cell-Cell Interactions In Vitro

Representative immunocytochemistry images display Human iPSC-Derived Astrocytes tri-cultured with forebrain neurons derived using the STEMdiff?-TF Forebrain Induced Neuron Differentiation Kit and microglia for 7 days using BrainPhys? hPSC Neuron Kit supplemented with STEMdiff? Microglia Supplement 2 (Component #100-0023 of STEMdiff? Microglia Differentiation Kit). Cells were stained for GFAP (green, astrocyte marker), MAP2 (pink, neuronal dendrite marker), IBA1 (cyan, common microglia marker), and DAPI (grey, nuclei). The presence of MAP2-positive neurons, GFAP-positive astrocytes, and IBA1-positive microglia confirms the successful establishment of tri-culture conditions and supports the viability and integration of astrocytes in a mixed neuron–microglia environment. Scale bar = 50 ?m.

Figure 8. Human iPSC-Derived Astrocytes Promote Neural Activity in Co-Culture with Human iPSC-Derived Neurons

Figure 8. Human iPSC-Derived Astrocytes Promote Neural Activity in Co-Culture with Human iPSC-Derived Neurons

Human iPSC-Derived Forebrain Neuron Precursor Cells (Catalog #200-0770) were cultured either alone or in a 1:1 co-culture with isogenic Human iPSC-Derived Astrocytes (Catalog #200-0980). Cells were plated on a 48-well CytoView MEA? Plate (Catalog #200-0872) and maintained in STEMdiff? Forebrain Neuron Maturation Medium (Catalog #08605). Electrical activity from 16 electrodes per well was recorded longitudinally using the Maestro Pro? MEA system (Catalog #200-0887). (A - B) Representative brightfield images show the morphology of neuron-only and neuron-astrocyte co-cultures on the MEA plate. (C - D) Raster plots on Day 21 illustrate spike activity in neuron-only versus co-culture conditions. Detected spikes (black lines), single-channel bursts (blue lines; defined as ≥5 spikes with inter-spike intervals [ISI] ≤100 ms), and network bursts (≥50 spikes across ≥35% of electrodes with ISI ≤100 ms) were quantified over time. Co-cultures showed a visibly higher level of neuronal activity on Day 21 compared to neurons alone. (E - G) Quantitative analyses revealed a progressive increase in (E) mean firing rate, (F) number of active electrodes, and (G) burst frequency over the 21-day period. Across all measures, neuron-astrocyte co-cultures consistently exhibited significantly greater electrophysiological activity than neuron-only cultures. hiPSC = human induced pluripotent stem cell; MEA = microelectrode array; ISI = inter-spike interval.

Protocols and Documentation

Find supporting information and directions for use in the Product Information Sheet or explore additional protocols below.

Document Type
Product Name
Catalog #
Lot #
Language
Document Type
Product Name
Catalog #
200-0980
Lot #
All
Language
English

Applications

This product is designed for use in the following research area(s) as part of the highlighted workflow stage(s). Explore these workflows to learn more about the other products we offer to support each research area.

Certain products are only available in select territories. Please contact your local Sales representative or Product & Scientific Support at techsupport@stemcell.com for further information.